Anthropic Faces Scrutiny Over Biotech Claims and IPO Prospects
Left 44%
Center 22%
Right 33%
4 left · 2 center · 3 right
What happened
Anthropic, an artificial intelligence company, confidentially filed an IPO prospectus with the U.S. Securities and Exchange Commission in June and released its S-1 publicly on October 26, planning to list on the Nasdaq Global Select Market under the ticker ANT. After Democrats won control of Congress and several key governorships in the U.S. midterms — including Gina Hinojosa's defeat of three-term Texas Republican Gov. Greg Abbott following a campaign for tighter limits on data-center construction — AI-related stocks sold off, the Nasdaq Composite closed more than 10 percent below its recent high, and Kalshi prediction-market odds that Anthropic would announce an IPO before December fell from over 85 percent to 57 percent. The S-1 showed revenue of $33.2 billion through the first nine months of the fiscal year ended September 30, up 1,206 percent, operating losses of $1.3 billion down from $5.2 billion a year earlier, and $895.4 billion in spending commitments, including $69.8 billion due within 12 months; an updated filing left October revenue blank. Bloomberg reported that a potential valuation near $2 trillion in early October had fallen to about $1.2-1.3 trillion, and people familiar with investor discussions said some viewed a recently discussed $1.5 trillion figure as high and questioned whether a roadshow expected the week of November 9 would proceed on time. Ramp data showed AI token spending grew only 1.5 percent across August and September after 42 percent growth in July, Anthropic said price cuts reduced revenue growth by about $600 million, and the company was expected to receive a high junk credit rating.
Sourcing check · Mostly on the record · 9 articles
6 of 8 articles cite a named source for the story. It was on the record from the first report.
What these terms mean and how they're counted
- On the record · names a source 6 of 8
- On the record means the article cites a source by name for the story's main claim: a person, or an institution speaking officially, such as a company statement or a named agency's spokesperson. The opposite is an unnamed source. The count is how many of the counted articles cite at least one such source; the names are everyone named across them, each once however the articles spell it. Here: Gil Luria, METR, Anthropic, Dario Amodei, Andreas Bender and Greg Brockman
- Primary evidence · cites a document or data 4 of 8
- Primary evidence means the article cites a record you could check yourself: a court filing or ruling, a dataset or report, a recording or transcript, an official statement or press release, market data. A quote is not a document. The count is how many articles cite one. Here: market data, regulatory filing, report, Ramp report
- Credits another outlet 0 of 8
- The article says the story comes from another outlet's reporting (“first reported by Reuters”). Those articles relay the story; they are not independent confirmation. Here: Each article presents its own reporting.
- Unnamed sources 3 of 8
- The main claim is attributed to people who are not identified: “people familiar with the matter”, “officials said”. The count is how many articles do this.
- How it developed
- When the first report landed and whether it named anyone; when the first named source and the first document appeared. Here: First report Nov 5, 18:02 UTC by TechCrunch, naming its source. First document within the hour, from Breitbart (regulatory filing).
- Not counted 1
- Opinion, analysis and video pieces, and articles too short to assess. Every count above is out of the counted articles. An article republished under a new headline is one article.
This is about who is cited, not whether the story is true. Each source below says what it names. How we count
Omitted — what each side leaves out
Unpacked
Left-leaning coverage treats Anthropic's IPO snag as a midterm shock and omits the live fight over price. CNBC reports Kalshi odds of a December announcement falling after Democrats took Congress, tying the move to fears of slower data-center buildout. It never says investors are rejecting a $1.5 trillion valuation or that October revenue was left blank in the updated S-1. The New York Post, on the right, reports both, which recasts the delay as a financing problem rather than only an election result.
Right-leaning coverage celebrates a listing while left-leaning coverage bets it may not happen. Breitbart headlines an "AI Coronation," and CNBC describes only falling announcement odds after an AI sell-off.
None of the coverage answers whether Anthropic has told its bankers to launch the roadshow or stand down.
Bottom line
CNBC's Anthropic IPO story never mentions investors walking off a $1.5 trillion valuation, so the snag sounds like a midterm hangover instead of a price fight.
The receipts — 1 fact one side's coverage lacks
- Some investors view a $1.5 trillion valuation as the high end and are pushing for a more attractive price before committing
The Left View
CNBC frames the Kalshi odds drop as investors repricing Anthropic's IPO after Democratic midterm victories and an AI-stock selloff. It reports concern that Democratic control of Congress "could slow data center construction, making the bet on AI less attractive," and quotes Texas Gov.-elect Hinojosa saying, "We will have laws to protect Texans and we need to stop what we are doing with data centers until we have those protections." The outlet ties that political risk to the Nasdaq's correction-level decline and steep weekly drops in Nvidia, Micron, and CoreWeave, even after a partial Friday rebound.
The Right View
Breitbart presents a possible mid-November debut as an "AI Coronation" that "will provide a huge boost to extreme leftist causes and the Effective Altruism (EA) movement" by enriching Silicon Valley figures it describes as embracing "extreme politics," including Democrat mega-donor Eric Schmidt, whose stake it estimates could add about $10 billion to his fortune. It cites David Sacks's claim that when AI executives call for a slowdown they aim "to capture the industry and exclude themselves from antitrust laws," not altruism. The New York Post reports investors pushing for a cheaper price than the recently discussed valuation and doubting whether the planned roadshow can proceed, warning that a delay "would likely fuel further concern over the health of the AI ecosystem" after state ballot measures "crystallized political opposition" to data centers. A companion Post article says Anthropic has touted biotechnology — including CEO Dario Amodei's line that "the thing that will work is actually curing cancer" — "in a bid to drive up its stock price," while scientists note no AI-developed drug has won full FDA approval and Vertex executive chairman Jeff Leiden called similar cure timelines "complete BS."
Our Take (balanced)
CNBC's strongest argument is that near-term IPO odds fell because investors treated Democratic midterm wins, exemplified by Hinojosa's data-center pause in Texas, as a direct threat to AI infrastructure buildout, a reading supported by the same-week Nasdaq correction and the Kalshi collapse. Right-leaning outlets' strongest argument is two-sided: if the listing proceeds it would, as Breitbart calculates from Schmidt's early stake, substantially enrich left-aligned Silicon Valley donors, while Post reporting and Ramp's stalled token-spend growth indicate investors already doubt that ongoing losses, massive compute commitments, price-cut revenue hits, and preclinical biotech claims can support the valuations recently floated. The central unresolved tension is whether the snag is primarily a post-election political shock to data centers or a broader judgment that Anthropic's growth and scientific promises cannot carry the offering — a question the concurrent selloff does not settle.
9 sources
- Anthropic IPO announcement odds drop on Kalshi following midterms and AI sell-off
- Investors brace for lower Anthropic valuation, calling $1.5 trillion a 'stretch'
- Why a new report on Anthropic automating AI development is alarming researchers
- Anthropic IPO meets AI backlash after midterms show stinging rebuke of data centers
- AI Coronation: Anthropic Shares Could Begin Trading the Week of November 16
- Anthropic’s IPO timing threatened by AI backlash, historic tech rout
- Anthropic is making biotech boasts, but scientists are wary of hype around ‘curing cancer’
- OpenAI president Greg Brockman says company could be IPO ready in 2027
- Ramp data shows AI spending stalling just as Anthropic nears its IPO
More stories
The week's bottom lines, in your inbox
One email a week: the five stories that mattered and what they actually mean. Free.